A simple question answered: Adding moderate-dosage lithium does not help patients with bipolar disorder

American Journal of Psychiatry

Volumn 170, Issue 1, 2013, Pages 9-11

  Dunlop, Boadie W ^a   Rakofsky, Jeffrey J ^a   Rapaport, Mark Hyman ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; LITHIUM CARBONATE;

BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; DEPRESSION; DRUG EFFICACY; EDITORIAL; FOLLOW UP; HUMAN; HYPOMANIA; LOW DRUG DOSE; MANIA; OUTPATIENT CARE; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; SUICIDAL IDEATION; SUICIDE;

EID: 84872094671     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2012.12111378     Document Type: Editorial

References (15)

1. Judd LL, Schettler PJ, Akiskal HS, Coryell W, Leon AC, Maser JD, Solomon DA: Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence. Arch Gen Psychiatry 2008; 65:386-394
2. Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, Ketter TA, Miklowitz DJ, Otto MW, Gyulai L, Reilly-Harrington NA, Nierenberg AA, Sachs GS, Thase ME: Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2006; 163:217-224
3. Marangell LB, Dennehy EB, Miyahara S, Wisniewski SR, Bauer MS, Rapaport MH, Allen MH: The functional impact of subsyndromal depressive symptoms in bipolar disorder: data from STEP-BD. J Affect Disord 2009; 114:58-67
4. Michalak EE, Murray G, Young AH, Lam RW: Quality of life impairment in bipolar disorder, in Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders: From Brain Functions to Clinical Practice. Edited by Ritsner M. New York, Springer, 2007, pp 163-174
5. Perlick DA, Clarkin JF, Sirey J, Raue P, Greenfield S, Struening E, Rosenheck R: Burden experienced by caregivers of persons with bipolar affective disorder. Br J Psychiatry 1999; 174:56-62
6. Cade JF: Lithium salts in the treatment of psychotic excitement. Med J Aust 1949; 2:349-352
7. Prien RF, Caffey EM Jr, Klett CJ: Comparison of lithium carbonate and chlorpromazine in the treatment of mania: report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiatry 1972; 26:146-153
8. Baldessarini RJ, Leahy L, Arcona S, Gause D, Zhang W, Hennen J: Patterns of psychotropic drug prescription for US patients with diagnoses of bipolar disorders. Psychiatr Serv 2007; 58:85-91
9. Nierenberg AA, Friedman ES, Bowden CL, Sylvia LG, Thase ME, Ketter T, Ostacher MJ, Leon AC, Reilly-Harrington N, Iosifescu DV, Pencina M, Severe JB, Calabrese JR: Lithium Treatment Moderate-Dose Use Study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. Am J Psychiatry 2013; 170:102-110
10. Prien RF, Caffey EM Jr, Klett CJ: Relationship between serum lithium level and clinical response in acute mania treated with lithium. Br J Psychiatry 1972; 120:409-414
11. Nemeroff CB, Evans DL, Gyulai L, Sachs GS, Bowden CL, Gergel IP, Oakes R, Pitts CD: Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001; 158:906-912
12. Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, Cole K, Lavelle J: Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 1989; 321:1489-1493
13. Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J: Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord 2006; 8:625-639
14. Suppes T, Dennehy EB, Hirschfeld RMA, Altshuler LL, Bowden CL, Calabrese JR, Crismon ML, Ketter TA, Sachs GS, Swann AC, Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder: The Texas Implementation of Medication Algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry 2005; 66:870-886
15. Pharmacogenomics of Mood Stabilizer Response. http://www.clinicaltrials. gov/ct2/show/NCT01272531?term=Pharmacogenomics+of+Bipolar+Disorder&rank=1